Our findings show that Nr2f1 mutant mice can be used as a model to reproduce the BBSOA syndrome and, more broadly, can serve as a tool to test possible therapeutic approaches aimed at counteracting ON neuropathies. This evidence concerns the gene NR2F1 and neuropathy.